ScholarLens Back to search
1989•PubMedRequires access

[Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].

Pierre Comte, P Vérin, Le Bras M

Open publisher page 0 citations

Abstract

Congenital ocular toxoplasmosis with recurrences must be treated by Spiramycin destroys trophozoites when they escape from the true cysts. Fansidar (Pyrimethamine + Sulfadoxine) seems to have less efficacity than Pyrimethamine with Sulfadiazine.

About this research paper

What this paper is about

Congenital ocular toxoplasmosis with recurrences must be treated by Spiramycin destroys trophozoites when they escape from the true cysts. Fansidar (Pyrimethamine + Sulfadoxine) seems to have less efficacity than Pyrimethamine with Sulfadiazine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Congenital ocular toxoplasmosis with recurrences must be treated by Spiramycin destroys trophozoites when they escape from the true cysts. Fansidar (Pyrimethamine + Sulfadoxine) seems to have less efficacity than Pyrimethamine with Sulfadiazine.

Key concepts: Spiramycin, Pyrimethamine, Sulfadiazine, Toxoplasmosis, Congenital toxoplasmosis, Medicine, Sulfadoxine, Pediatrics

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
[Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar]. — Research Paper | ScholarLens